RITUXIMAB 500 mg/50 mL (Enfiera) Injection

Uses of RITUXIMAB 500 mg

• Treats non-Hodgkin lymphoma
• Treats chronic lymphocytic leukemia (CLL)
• Treats rheumatoid arthritis with other medications
• Treats certain autoimmune disorders, such as granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)
• Used as part of combination treatment regimens

Benefits of RITUXIMAB

• Targets abnormal B cells with precision
• Helps slow the progression of blood cancers
• Reduces symptoms of autoimmune diseases
• Can improve long-term treatment outcomes
• Effective when combined with other therapies

How Does RITUXIMAB 500 mg Work?

Rituximab 500 mg works by targeting the CD20 protein found on the surface of B lymphocytes (B cells). It binds to these cells and triggers their destruction by the immune system. This helps eliminate cancerous B cells and reduces the abnormal immune response in autoimmune diseases.

Side Effects

• Infusion-related reactions
• Fever
• Chills
• Fatigue
• Nausea
• Headache
• Increased risk of infections
• Skin rash

Precautions

• Administer only under the supervision of a healthcare professional.
• Patients should be monitored during and after the infusion for allergic or infusion-related reactions.
• Inform your doctor if you have hepatitis B, heart disease, or active infections.
• Regular blood tests may be required during treatment.
• Tell your healthcare provider about all medications and vaccines you are taking or planning to receive.
• Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
• Seek immediate medical attention if you develop signs of a serious infection, breathing difficulties, or severe skin reactions.